Back

Use of beta-blockers and in-hospital mortality in patients with Takotsubo cardiomyopathy - a systematic review and meta-analysis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Novel therapies in heart failure: impact on outcomes Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Caroline Fischer Bacca

University Center for the Development of Alto Vale - UNIDAVI, Rio do Sul (Brazil)

7 More presentations in this session

Presentation thumbnail
Clinical and echocardiographic long-term follow-up after transcoronary ablation of septal hypertrophy - a retrospective register analysis
Doctor F. Becker (Munich, DE)
Abstract Slides Video
Presentation thumbnail
High-dose guideline-directed medical therapy at discharge reduces mortality in hospitalized patients with heart failure with reduced ejection fraction: evidence from the HEROES study
Professor P. Krzesinski (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
The association between malnutrition and adverse outcome in patients with chronic heart failure who underwent cardiac resynchronization therapy
Doctor Y. Ono (Chiba, JP)
Abstract Slides Video
Presentation thumbnail
Both BNP and left ventricle diastolic diameter can predict all-cause mortality among Colombian asymptomatic, Trypanosoma cruzi-seropositive carriers after 22 years: results of the CHICAMOCHA cohort
Professor J. Villar (Bogota, CO)
Abstract Slides Video
Presentation thumbnail
Prevalence and outcomes of iron deficiency based on transferrin saturation in patients with acute heart failure
Doctor K. Tsuda (Takatsuki, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Novel therapies in heart failure: impact on outcomes

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Beta-blocker interruption or continuation after myocardial infarction? a systematic review and meta-analysis
thumbnail
Congress Presentation
Beta-blockers after myocardial infarction: are we treating without evidence? a systematic review and meta-analysis
thumbnail
Congress Presentation
Utility of perioperative beta blocker therapy in patients undergoing cardiac surgery

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources